### 38492 Federal Register / Vol. 75, No. 127 / Friday, July 2, 2010 / Notices

23 7 U.S.C. 19(a). 24 5 U.S.C. 601 et seq.

25 66 FR 42256, 42268 (Aug. 10, 2001). 26 7 U.S.C. 1a(29). on Federal agencies, including the Commission, in connection with their conducting or sponsoring any collection of information as defined by the PRA. Certain provisions of Commission rule 36.3 impose new regulatory and reporting requirements on ECMs, resulting in information collection requirements within the meaning of the PRA. OMB previously has approved and assigned OMB control number 3038– 0060 to this collection of information. b. Cost-Benefit Analysis

Section 15(a) of the CEA 23 requires the Commission to consider the costs and benefits of its actions before issuing an order under the Act. By its terms, section 15(a) does not require the Commission to quantify the costs and benefits of an order or to determine whether the benefits of the order outweigh its costs; rather, it requires that the Commission ‘‘ consider’’ the costs and benefits of its actions. Section 15(a) further specifies that the costs and benefits shall be evaluated in light of five broad areas of market and public concern: (1) Protection of market participants and the public; (2) efficiency, competitiveness and financial integrity of futures markets; (3) price discovery; (4) sound risk management practices; and (5) other public interest considerations. The Commission may in its discretion give greater weight to any one of the five enumerated areas and could in its discretion determine that, notwithstanding its costs, a particular order is necessary or appropriate to protect the public interest or to effectuate any of the provisions or accomplish any of the purposes of the Act. The Commission has considered the costs and benefits in light of the specific provisions of section 15(a) of the Act and has concluded that the Order, required by Congress to strengthen federal oversight of exempt commercial markets and to prevent market manipulation, is necessary and appropriate to accomplish the purposes of section 2(h)(7) of the Act.

When a futures contract begins to serve a significant price discovery function, that contract, and the ECM on which it is traded, warrants increased oversight to deter and prevent price manipulation or other disruptions to market integrity, both on the ECM itself and in any related futures contracts trading on DCMs. An Order finding that a particular contract is a SPDC triggers this increased oversight and imposes obligations on the ECM calculated to accomplish this goal. The increased oversight engendered by the issue of a SPDC Order increases transparency and helps to ensure fair competition among ECMs and DCMs trading similar products and competing for the same business. Moreover, the ECM on which the SPDC is traded must assume, with respect to that contract, all the responsibilities and obligations of a registered entity under the CEA and Commission regulations. Additionally, the ECM must comply with nine core principles established by section 2(h)(7) of the Act—including the obligation to establish position limits and/or accountability standards for the SPDC. Amendments to section 4(i) of the CEA authorize the Commission to require reports for SPDCs listed on ECMs. These increased responsibilities, along with the CFTC’s increased regulatory authority, subject the ECM’s risk management practices to the Commission’s supervision and oversight and generally enhance the financial integrity of the markets.

The Commission has concluded that ICE’s SZS contract, which is the subject of the attached Order, is not a SPDC; accordingly, the Commission’s Order imposes no additional costs and no additional statutorily or regulatory mandated responsibilities on the ECM. c. Regulatory Flexibility Act

The Regulatory Flexibility Act ( ‘‘RFA’’ ) 24 requires that agencies consider the impact of their rules on small businesses. The requirements of CEA section 2(h)(7) and the Part 36 rules affect exempt commercial markets. The Commission previously has determined that exempt commercial markets are not small entities for purposes of the RFA. 25 Accordingly, the Chairman, on behalf of the Commission, hereby certifies pursuant to 5 U.S.C. 605(b) that this Order, taken in connection with section 2(h)(7) of the Act and the Part 36 rules, will not have a significant impact on a substantial number of small entities.

VI. Order
Order Relating to the Fuel Oil-180 Singapore Swap Contract

After considering the complete record in this matter, including the comment letters received in response to its request for comments, the Commission has determined to issue the following Order:

The Commission, pursuant to its authority under section 2(h)(7) of the Act, hereby determines that the Fuel Oil-180 Singapore Swap contract, traded on the IntercontinentalExchange, Inc., does not at this time satisfy the material price reference and material liquidity criteria for significant price discovery contracts. Moreover, under Commission Guidance material liquidity alone cannot support a significant price discovery finding for the Fuel Oil-180 Singapore Swap contract.

Consistent with this determination, the IntercontinentalExchange, Inc., is not considered a registered entity 26 with respect to the Fuel Oil-180 Singapore Swap contract and is not subject to the provisions of the Commodity Exchange Act applicable to registered entities. Further, the obligations, requirements and timetables prescribed in Commission rule 36.3(c)(4) governing core principle compliance by the IntercontinentalExchange, Inc., are not applicable to the Fuel Oil-180 Singapore Swap contract with the issuance of this Order.

This Order is based on the representations made to the Commission by the IntercontinentalExchange, Inc., dated July 27, 2009, and November 13, 2009, and other supporting material. Any material change or omissions in the facts and circumstances pursuant to which this order is granted might require the Commission to reconsider itscurrent determination that the Fuel Oil180 Singapore Swap contract is not a significant price discovery contract. Additionally, to the extent that it continues to rely upon the exemption in Section 2(h)(3) of the Act, the IntercontinentalExchange, Inc., must continue to comply with all of the applicable requirements of Section 2(h)(3) and Commission Regulation

36.3.

Issued in Washington, DC on June 25, 2010, by the Commission. David A. Stawick, Secretary of the Commission.

[FR Doc. 2010–16209 Filed 7–1–10; 8:45 am]

**BILLING CODE 6351–01–P**

**CONSUMER PRODUCT SAFETY COMMISSION** 

**Sunshine Act Meetings**

**TIME AND DATE :**  Wednesday, June 30, 2010, 2 p.m.–3 p.m.

**PLACE :**  Hearing Room 420, Bethesda Towers, 4330 East West Highway, Bethesda, Maryland.

**STATUS :**  Commission Meeting—Open to the Public.


### 38493 Federal Register / Vol. 75, No. 127 / Friday, July 2, 2010 / Notices

**MATTERS TO BE CONSIDERED :** 

1. Accreditation for Third Party Conformity Assessment Bodies for Testing for Children’s Products: Carpets and Rugs.

2. Accreditation for Third Party Conformity Assessment Bodies for Testing for Children’s Products: Vinyl Plastic Film.

A live Webcast of the Meeting can be viewed at http://www.cpsc.gov/webcast.

For a recorded message containing the latest agenda information, call (301)

504–7948.

**CONTACT PERSON FOR MORE INFORMATION :**  Todd A. Stevenson, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, MD 20814, (301)

504–7923.

Dated: June 25, 2010. Todd A. Stevenson, Secretary. [FR Doc. 2010–16316 Filed 6–30–10; 4:15 pm]

**BILLING CODE 6355–01–P**

**DEPARTMENT OF DEFENSE**

**Office of the Secretary**

**Board of Regents of the Uniformed Services University of the Health**  **Sciences**

**AGENCY :**  Uniformed Services University of the Health Sciences (USU), DoD.

**ACTION :**  Quarterly meeting notice.

**SUMMARY :**  Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended) and the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), this notice announces a meeting of the Board of Regents of the Uniformed Services University of the Health Sciences on August 3, 2010, in Bethesda, MD.

**DATES :**  The meeting will be held on Tuesday, August 3, 2010, from 8 a.m. to 12 noon (open session) and from 12 noon to 1:30 p.m. (closed session).

**ADDRESSES :**  The meeting will be held at the Everett Alvarez Jr. Board of Regents Room (D 3001), Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.

**FOR FURTHER INFORMATION CONTACT :**  Janet S. Taylor, Designated Federal Official, 4301 Jones Bridge Road, Bethesda, MD 20814; telephone 301– 295–3066. Ms. Taylor can also provide base access procedures.

**SUPPLEMENTARY INFORMATION :**  Purpose of the Meeting

Meetings of the Board of Regents assure that USU operates in the best traditions of academia. An outside Board is necessary for institutional accreditation.
Agenda

The actions that will take place include the approval of minutes from the Board of Regents Meeting held May 14, 2010; acceptance of reports from working committees; approval of faculty appointments and promotions; and the awarding of master’s and doctoral degrees in the biomedical sciences and public health. The Acting President, USU will also present a report. These actions are necessary for the University to pursue its mission, which is to provide outstanding health care practitioners and scientists to the uniformed services.
Meeting Accessibility

Pursuant to Federal statute and regulations (5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102– 3.165) and the availability of space, the meeting is open to the public from 8a.m. to 12 noon. Seating is on a firstcome basis. The closed portion of this meeting (from 12 noon to 1:30 p.m.) is authorized by 5 U.S.C. 552b(c)(6) as the subject matter involves personal and private observations.

Written Statements

Interested persons may submit a written statement for consideration by the Board of Regents. Individuals submitting a written statement must submit their statement to the Designated Federal Official ( see **FOR FURTHER**
**INFORMATION CONTACT** ). If such statement is not received at least 10 calendar days prior to the meeting, it may not be provided to or considered by the Board of Regents until its next open meeting. The Designated Federal Official will review all timely submissions with the Board of Regents Chairman and ensure such submissions are provided to Board of Regents Members before the meeting. After reviewing the written comments, submitters may be invited to orally present their issues during the August 2010 meeting or at a future meeting.

Dated: June 28, 2010. Mitchell S. Bryman, Alternate OSD Federal Register Liaison Officer, Department of Defense.

[FR Doc. 2010–16092 Filed 7–1–10; 8:45 am]

**BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE** 

**Office of the Secretary**

**Federal Advisory Committee; Defense Health Board (DHB) Meeting** 

**AGENCY :**  Department of Defense (DoD).

**ACTION :**  Notice of meeting.

**SUMMARY :**  Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150, and in accordance with section 10(a)(2) of Public Law, DoD announces a meeting of the Defense Health Board (DHB) on August 18 and 19, 2010, in West Point, NY.

**DATES :**  The meeting will be held on August 18 (from 8 a.m. to 5 p.m.) and on August 19, 2010 (from 7 a.m. to 2 p.m.).

**ADDRESSES :**  The meeting will be held at the Thayer Hotel, 674 Thayer Road, West Point, NY 10996.

**FOR FURTHER INFORMATION CONTACT :**  Commander Edmond F. Feeks, Executive Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg Pike, Suite 810, Falls Church, Virginia 22041–3206, (703) 681–8448, ext. 1228, Fax: (703) 681–3317, edmond.feeks@tma.osd.mil.

**SUPPLEMENTARY INFORMATION :**  Additional information, agenda updates, and meeting registration are available online at the Defense Health Board Web site, http://www.ha.osd.mil/dhb.
Purpose of the Meeting

The purpose of the meeting is to address and deliberate pending and new Board issues and provide briefings for Board members on topics related to ongoing Board business.
Agenda
August 18, 2010

8 a.m.–9:15 a.m. (Closed Administrative Working Meeting).

9:30 a.m.–12:45 p.m. (Open Session). 12:45 p.m.–1:45 p.m. (Closed Administrative Working Meeting).

1:45 p.m.–5 p.m. (Open Session).
August 19, 2010

7 a.m.–2 p.m. (Closed Administrative Working Meeting).
Meeting Topics

On August 18, 2010, the DHB will receive briefings on military health needs and priorities. The following Defense Health Board Subcommittees will present updates to the Board: Department of Defense Task Force on